Vascular Biogenics Ltd reports results for the quarter ended in March - Earnings Summary

Notable Labs

11/05/2021 15:59

* Vascular Biogenics Ltd  VBLT.OQ  reported a quarterly adjusted
loss of 12 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 13 cents per share.
* Revenue fell 49.5% to $185.00 thousand from a year ago; 
analysts expected $200.00 thousand. 
* Vascular Biogenics Ltd's reported EPS for the quarter was a
loss of 12 cents​.
* The mean earnings estimate of analysts had risen by about 3.7%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Vascular Biogenics Ltd shares had risen by 0.5% this
quarter and gained 6.3% so far this year.
* The company reported a quarterly loss of $6.28 million.
* Wall Street's median 12-month price target for Vascular
Biogenics Ltd is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 02:59 p.m. GMT.
​All figures in US dollars